Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2022		81,259,676
Beginning balance at Dec. 31, 2022	$ 672,435	$ 8	$ 714,871	$ (42,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,441,787
Issuance of common stock upon exercise of stock options	12,881	$ 1	12,880
Issuance of common stock upon settlement of restricted stock units (in shares)		3,170,158
Shares withheld related to net share settlement of restricted stock units (in shares)		(777)
Shares withheld related to net share settlement of restricted stock units	(15)		(15)
Stock-based compensation expense	181,705		181,705
Issuance of common stock under employee stock purchase plan (in shares)		459,459
Issuance of common stock under employee stock purchase plan	8,431		8,431
Net (loss) income	(240,132)			(240,132)
Ending balance (in shares) at Dec. 31, 2023		86,330,303
Ending balance at Dec. 31, 2023	635,305	$ 9	917,872	(282,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		3,159,674
Issuance of common stock upon exercise of stock options	21,414		21,414
Issuance of common stock upon settlement of restricted stock units (in shares)		3,646,748
Shares withheld related to net share settlement of restricted stock units (in shares)		(568)
Shares withheld related to net share settlement of restricted stock units	(22)		(22)
Stock-based compensation expense	137,720		137,720
Issuance of common stock under employee stock purchase plan (in shares)		333,564
Issuance of common stock under employee stock purchase plan	7,685		7,685
Purchase of capped calls	(40,883)		(40,883)
Settlement of capped calls	580		580
Net (loss) income	$ (128,581)			(128,581)
Ending balance (in shares) at Dec. 31, 2024	93,469,721	93,469,721
Ending balance at Dec. 31, 2024	$ 633,218	$ 9	1,044,366	(411,157)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,580,432	1,580,432
Issuance of common stock upon exercise of stock options	$ 16,860	$ 1	16,859
Issuance of common stock upon settlement of restricted stock units (in shares)		2,763,508
Shares withheld related to net share settlement of restricted stock units (in shares)		(118)
Shares withheld related to net share settlement of restricted stock units	(9)		(9)
Stock-based compensation expense	141,332		141,332
Issuance of common stock under employee stock purchase plan (in shares)		219,818
Issuance of common stock under employee stock purchase plan	8,449		8,449
Purchase of capped calls	(55,200)		(55,200)
Settlement of capped calls	564		564
Net (loss) income	$ 53,601			53,601
Ending balance (in shares) at Dec. 31, 2025	98,033,361	98,033,361
Ending balance at Dec. 31, 2025	$ 798,815	$ 10	$ 1,156,361	$ (357,556)